Regeneron Pharmaceuticals, Inc.

Rhenman & Partners Asset Management AB REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

61,400

Value ($000)

47,393

Weight

4.4%

2013 Q4 - 2025 Q4 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	47,393	4.4%	61,400	12/31/2025
2025 Q3	11/13/2025	20,298	2.2%	36,100	9/30/2025
2025 Q2	8/13/2025	14,543	1.8%	27,700	6/30/2025
2014 Q2	7/31/2014	6,356	1.9%	22,500	6/30/2014
2014 Q1	5/14/2014	16,753	5.1%	55,792	3/31/2014
2013 Q4	2/14/2014	10,184	4.1%	37,000	12/31/2013